Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 319, Issue 5, Pages L843-L847Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00391.2020
Keywords
airway smooth muscle; estrogen; SARS-CoV-2; sex difference; testosterone
Categories
Funding
- NIH National Heart, Lung, and Blood Institute [R01-HL123494, R01-HL123494-02S1, R01-HL146705, R01-HL088029, R01-HL142061]
- National Institute of GeneralMedical Sciences Grant [U54GM128729]
Ask authors/readers for more resources
The incidence, severity, and mortality of ongoing coronavirus infectious disease 19 (COVID-19) is greater in men compared with women, but the underlying factors contributing to this sex difference are still being explored. In the current study, using primary isolated human airway smooth muscle (ASM) cells from normal males versus females as a model, we explored the effect of estrogen versus testosterone in modulating the expression of angiotensin converting enzyme 2 (ACE2), a cell entry point for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Using confocal imaging, we found that ACE2 is expressed in human ASM. Furthermore, Western analysis of ASM cell lysates showed significantly lower ACE2 expression in females compared with males at baseline. In addition, ASM cells exposed to estrogen and testosterone for 24 h showed that testosterone significantly upregulates ACE2 expression in both males and females, whereas estrogen downregulates ACE2, albeit not significant compared with vehicle. These intrinsic and sex steroids induced differences may help explain sex differences in COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available